Thiadiazole IRAK4 compounds
US11046686B2 · kind B2 · utility
2Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2019 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Aug 13, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.